Pro PG receives S19 A for Bleomycin Injection (market shortage Australia) - stock available now.
- @propharmgroup
- Apr 20, 2019
- 1 min read
Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020.
Bleomycin Injection is currently experiencing a shortage of supply in Australia.
Product: Bleomycin Injection 15 Units S19a
Stock availability: Stock is available now at Wholesalers Nationally.
Ordering
Orders can be placed via Wholesalers Symbion and Central Healthcare Services (CHS) via the below PDE numbers.
Symbion PDE: 629103
CHS PDE: BLEI15PR
http://www.pbs.gov.au/info/news/2019/05/pbs-summary-of-changes-1-june-2019
